Stay updated on Safety of DCC-2618 in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page.

Latest updates to the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page
- Check6 days agoChange DetectedA sitewide NIH notice announces updates during a terminology transition, including use of “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check13 days agoChange DetectedThe site revision changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check34 days agoChange DetectedThe 403 error page snippet and the Home link were removed, indicating the page no longer displays the 403 Forbidden state and now shows the standard site layout.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error screen instead of the study details, with the site header and footer visible, indicating the record is unavailable and the page is serving a generic error response.SummaryDifference21%

- Check48 days agoChange DetectedNo changes were reported for the page; the study details page remains as shown with the existing content.SummaryDifference0.1%

Stay in the know with updates to Safety of DCC-2618 in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page.